Investors / United States / Boxer Capital
Boxer Capital
Venture capital · San Diego, CA, United States · North America
Boxer Capital Management is a biotechnology investment firm that invests in specialized and precision medicine companies across private and public markets. It conducts fundamental, research-based investing across all stages of the biotechnology ecosystem, from company building and early-stage to late-stage, crossover private investments and public markets.
Invests inHealthcare & Biotech
In its own wordsbiotechnologyprecision medicinelife sciencestherapeuticspublic marketscrossover
Your fit with Boxer Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBoxer Capital lists 40 checked portfolio companies on its own site and is named in 4 funding rounds. Its most frequent entry is Growth, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (90%), AI & Machine Learning (5%) and Fintech (3%). 91% of its companies are based in United States. It invests most often alongside Nextech Invest, RA Capital and Avoro Capital Advisors.
Counts come from funding rounds that name Boxer Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Boxer Capital's whole history. Rounds on record name 4 companies; its own site lists 40. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 25% |
| Series B | 25% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 77th | 40 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 56th | 3% of companies confirmed by a round |
| Sector focus | 96th | 90% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Nextech Invest | 10 |
| RA Capital | 7 |
| Avoro Capital Advisors | 6 |
| Casdin Capital | 6 |
| Foresite Capital | 6 |
| ARCH Venture Partners | 4 |
| Frazier Life Sciences | 4 |
| Versant Ventures | 4 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3895%
- No longer answers00%
- Points to another company25%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 90% | 15% |
| AI & Machine Learning | 5% | 18% |
| Fintech | 3% | 12% |
| Crypto & Web3 | 3% | 1% |
Co-investor network
who it backs companies with, and who they back togetherCompare Boxer Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Boxer Capital| Date | Company | Stage |
|---|---|---|
| 30 Jun 2026 | Series C+ | |
| 12 Jan 2026 | Series B | |
| 28 Oct 2025 | Series A |
Round details for Boxer Capital
Amounts, full round histories and every co-investor in Boxer Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
40 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Akero Therapeutics is pioneering novel therapies to transform the lives of people living with serious metabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Aligos Therapeutics develops therapies for liver and viral diseases | Healthcare & Biotech | Portfolio page | ||
| Alterome Therapeutics is a clinical-stage precision oncology company that develops therapies for cancer treatments. | Healthcare & Biotech | Portfolio page | ||
| Avidity Biosciences is developing RNA therapeutics for rare muscle diseases | Healthcare & Biotech | Portfolio page | ||
| BioAtla develops novel therapeutics with improved therapeutic index that are safer and more effective for treating cancer | Healthcare & Biotech | Portfolio page | ||
| The company creates novel covalent small molecules to treat serious and life-threatening diseases. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Boundless Bio develops therapies for patients with intractable oncogene amplified cancers. | Healthcare & Biotech | Portfolio page | ||
| Cabaletta Bio develops T cell therapies to treat autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| Centessa Pharmaceuticals develops and pursues medicines for patients with various disorders, including sleep-wake, neurological, neurodegenerative and neuropsychiatric disorders. | Healthcare & Biotech | Portfolio page | ||
| Connect Biopharma is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and COPD. | Healthcare & Biotech | Portfolio page | ||
| Cougar Biotechnology, Inc. is a company with a specific focus on the field of oncology. | Healthcare & Biotech | Portfolio page | ||
| Encoded Therapeutics develops genetic medicines to address the root cause of neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Flare Therapeutics designs small molecules to treat disease, particularly cancer, by regaining transcriptional control hijacked by cancer cells. | Healthcare & Biotech | Jun 2026Series C+ | Page + round | |
| G1 Therapeutics develops and delivers next generation therapies to improve the lives and outcomes of people living with cancer. | Healthcare & Biotech | Portfolio page | ||
| Incyclix Bio is a company advancing precision treatments that target the aberrant proliferation driving many cancers. | Healthcare & Biotech | Portfolio page | ||
| Kiniksa Pharmaceuticals develops and evaluates medicines, including an investigational monoclonal antibody for recurrent pericarditis | Healthcare & Biotech | Portfolio page | ||
| Milestone Pharmaceuticals develops treatments for self-administration outside the emergency department or healthcare setting for people with acute episodes of paroxysmal supraventricular tachycardia and other episodic cardiovascular conditions. | Healthcare & Biotech | Portfolio page | ||
| Mirador Therapeutics develops precision medicines for immune-mediated inflammatory and fibrotic diseases. | Healthcare & Biotech | Jan 2026Series B | Funding round | |
Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- boxercap.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 13 May 2024
- Companies checked
- 40
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Boxer Capital's profile as data
Pull Boxer Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/boxercap.com
# also
GET /v1/firms/boxercap.com/portfolio
GET /v1/firms/boxercap.com/coinvestors
GET /v1/firms/boxercap.com/news